Get the Stockscreener App
1.72
0.00%
0.00
Zenvia Inc Stock (ZENV) Latest News
Zenvia Inc. reveals shareholder meeting outcomes By Investing.com - Investing.com South Africa
Zenvia Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Zenvia Inc. reveals shareholder meeting outcomes - Investing.com
Zenvia Approves Financials and Strengthens Market Position - TipRanks
Zenvia Inc. (NASDAQ:ZENV) Q3 2024 Earnings Call Transcript - Insider Monkey
One Zenvia Insider Raised Stake By 964% In Previous Year - Yahoo Finance
Zenvia, Inc. Reports Strong Q3 2024 Growth - TipRanks
Zenvia Reports Strong Q3 Financial Turnaround - TipRanks
Zenvia Reports Strong Q3 Growth and New Platform Launch - TipRanks
Why Symbotic Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
Zenvia Inc (ZENV) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Zenvia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Zenvia Inc(ZENV) Price Target Increased by 5.68% to 1.58 - MSN
Zenvia Inc (ZENV) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Revenues Working Against Zenvia Inc.'s (NASDAQ:ZENV) Share Price Following 26% Dive - Simply Wall St
Deutsche Bank Aktiengesellschaft Raises Blackstone (NYSE:BX) Price Target to $182.00 - Defense World
BTIG Research Forecasts Strong Price Appreciation for Consensus Cloud Solutions (NASDAQ:CCSI) Stock - Defense World
ARB IOT Group Limited (NASDAQ:ARBB) Short Interest Up 41,735.7% in October - Defense World
Vanguard Growth ETF Portfolio (TSE:VGRO) Stock Price Down 0.3% – Should You Sell? - Defense World
Bespoke Extracts (OTCMKTS:BSPK) Shares Down 11.7% – Should You Sell? - Defense World
Repsol (OTCMKTS:REPYF) Stock Price Down 0.1% – Here’s What Happened - Defense World
Zenvia Inc. (NASDAQ:ZENV) Short Interest Update - MarketBeat
ZENVIA sets agenda for fiscal third quarter and first nine months 2024 results - StockTitan
Servizi Italia Shows Revenue Growth Amid Regional Variations - MSN
This Zenvia Insider Increased Their Holding By 964% Last Year - Simply Wall St
Zenvia Inc. (NASDAQ:ZENV) Q2 2024 Earnings Call Transcript - MSN
Nxu shares jump on proposed merger with Verde Bioresins - MSN
Zenvia CMO Marcelo Wakatsuki steps down, interim named By Investing.com - Investing.com South Africa
Zenvia Inc. Announces Leadership Change in Marketing - TipRanks
Zenvia CMO Marcelo Wakatsuki steps down, interim named - Investing.com UK
Zenvia establishes at-the-market equity programme in Brazil - Latin Lawyer
Zenvia Customer Cloud hits the market with AI to revolutionize Brand-CX - Martechcube
Zenvia Customer Cloud hits the market with AI to revolutionize Brand-Customer experiences - StockTitan
Zenvia Inc. (NASDAQ:ZENV) Short Interest Up 24.6% in September - MarketBeat
Zenvia Inc. (NASDAQ:ZENV) Short Interest Down 59.9% in September - MarketBeat
Affinity Asset Advisors LLC Invests $3.84 Million in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com Canada
Is this affordable and accessible eyewear brand worth the hype? - Reviewed
Wedbush lifts Zentalis Pharmaceuticals Inc [ZNTL] price estimate. Who else is bullish? - The DBT News
Trading Day Review: Zevra Therapeutics Inc (ZVRA) Loses Momentum, Closing at 7.53 - The Dwinnex
Adversity is less terrifying than hope: Zentalis Pharmaceuticals Inc (ZNTL) - SETE News
You might want to take a look at Zevra Therapeutics Inc (ZVRA) now - SETE News
Potential Price Increase for Zentalis Pharmaceuticals Inc (ZNTL) After Recent Insider Activity - Knox Daily
Daily Market Movement: Zentalis Pharmaceuticals Inc (ZNTL) Sees a 11.41 Increase, Closing at 4.10 - The Dwinnex
Zenith UK appoints Sannah Rogers chief executive - CampaignLive
Zendaya's baby pics that show she's always been that girl - Hindustan Times
Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com Canada
FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor - Pharmaceutical Technology
Zevra Therapeutics Inc (ZVRA)’s stock decline to 7.78 per share - US Post News
Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies - Zacks Investment Research
Zeneara Reviews"HYPE-LEGIT" HAPPY Customer or Controversy? - openPR
IPO Radar: Applied Nutrition, Zenas BioPharma, BingEx - The Armchair Trader
9.94%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):